May 28, 2025 -- Global Lyme Alliance (GLA), the leading nonprofit dedicated to combatting Lyme disease through research, awareness, and patient support, is pleased to announce the opening of its 2025 research grant cycle. GLA prioritizes research that accelerates the development of innovative diagnostics, elucidates disease mechanisms, and advances novel treatment strategies for Lyme and other tick-borne diseases. A particular emphasis is placed on understanding and addressing post-treatment and chronic manifestations of Lyme disease. Applicants may request up to $175,000 per year, inclusive of up to 10% indirect costs, for projects lasting one to two years.
GLA’s research grant application process consists of two stages:
“At a time when federal support for scientific research is more vulnerable, we’re proud that GLA continues to offer meaningful and sustained backing to investigators advancing the field of Lyme disease,” said Armin Alaedini, PhD, Chief Scientific Officer. “This grant cycle underscores our commitment to ensuring continued scientific momentum in an area where progress is urgently needed, while supporting translational research that can lead to tangible improvements in diagnosis, treatment, and outcomes for patients affected by tick-borne diseases.”
For more information about GLA’s research grant program and application process, click here.
***